TY - JOUR
T1 - Understanding the pathophysiology of idiopathic intracranial hypertension (IIH)
T2 - a review of recent developments
AU - Colman, Blake D.
AU - Boonstra, Frederique
AU - Nguyen, Minh N.L.
AU - Raviskanthan, Subahari
AU - Sumithran, Priya
AU - White, Owen
AU - Hutton, Elspeth J.
AU - Fielding, Joanne
AU - Van Der Walt, Anneke
N1 - Funding Information:
PS has co-authored manuscripts with medical writing provided by Novo Nordisk and Eli Lilly. She is supported by an Investigator Grant from the National Health and Medical Research Council (1178482). JF receives funding from Genzyme and Biogen and has received honorarium from Novartis. AvdW has received travel support and served on advisory boards for Novartis, Biogen, Merck Serono, Roche and Teva. She receives grant support from the National Health and Medical Research Council of Australia and MS Research Australia.
Publisher Copyright:
© 2023 Author(s) (or their employer(s)).
PY - 2024
Y1 - 2024
N2 - Idiopathic intracranial hypertension (IIH) is a condition of significant morbidity and rising prevalence. It typically affects young people living with obesity, mostly women of reproductive age, and can present with headaches, visual abnormalities, tinnitus and cognitive dysfunction. Raised intracranial pressure without a secondary identified cause remains a key diagnostic feature of this condition, however, the underlying pathophysiological mechanisms that drive this increase are poorly understood. Previous theories have focused on cerebrospinal fluid (CSF) hypersecretion or impaired reabsorption, however, the recent characterisation of the glymphatic system in many other neurological conditions necessitates a re-evaluation of these hypotheses. Further, the impact of metabolic dysfunction and hormonal dysregulation in this population group must also be considered. Given the emerging evidence, it is likely that IIH is triggered by the interaction of multiple aetiological factors that ultimately results in the disruption of CSF dynamics. This review aims to provide a comprehensive update on the current theories regarding the pathogenesis of IIH.
AB - Idiopathic intracranial hypertension (IIH) is a condition of significant morbidity and rising prevalence. It typically affects young people living with obesity, mostly women of reproductive age, and can present with headaches, visual abnormalities, tinnitus and cognitive dysfunction. Raised intracranial pressure without a secondary identified cause remains a key diagnostic feature of this condition, however, the underlying pathophysiological mechanisms that drive this increase are poorly understood. Previous theories have focused on cerebrospinal fluid (CSF) hypersecretion or impaired reabsorption, however, the recent characterisation of the glymphatic system in many other neurological conditions necessitates a re-evaluation of these hypotheses. Further, the impact of metabolic dysfunction and hormonal dysregulation in this population group must also be considered. Given the emerging evidence, it is likely that IIH is triggered by the interaction of multiple aetiological factors that ultimately results in the disruption of CSF dynamics. This review aims to provide a comprehensive update on the current theories regarding the pathogenesis of IIH.
KW - HEADACHE
KW - NEUROOPHTHALMOLOGY
UR - http://www.scopus.com/inward/record.url?scp=85174352058&partnerID=8YFLogxK
U2 - 10.1136/jnnp-2023-332222
DO - 10.1136/jnnp-2023-332222
M3 - Review Article
C2 - 37798095
AN - SCOPUS:85174352058
SN - 0022-3050
VL - 95
SP - 375
EP - 383
JO - Journal of Neurology, Neurosurgery and Psychiatry
JF - Journal of Neurology, Neurosurgery and Psychiatry
IS - 4
ER -